Vigene’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Vigene is a provider of molecular cloning and viral vector-based gene delivery services for research and clinical applications Read more

5 Followers on Owler
5 Followers on Owler
5 Followers on Owler
5 Followers on Owler

Vigene is a provider of molecular cloning and viral vector-based gene delivery services for research and clinical applications Read more

Zairen Sun's photo - Chairman & CEO of Vigene

Chairman & CEO

Zairen Sun

CEO Approval Rating

86/100

Founded:

2012

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Brammer Bio is a top competitor of Vigene. Brammer Bio was founded in 2016, and is headquartered in Cambridge, Massachusetts. Brammer Bio is in the Pharmaceuticals industry. Brammer Bio generates $238.4M more revenue vs. Vigene.

Sirion-Biotech is seen as one of Vigene's top competitors. Sirion-Biotech is headquartered in Martinsried, Bavaria, and was founded in 2005. Like Vigene, Sirion-Biotech also competes in the Biotechnology field. Sirion-Biotech generates 32% the revenue of Vigene.

IvexSol has been one of Vigene's top competitors. IvexSol's headquarters is in Worcester, Massachusetts, and was founded in 2019. Like Vigene, IvexSol also operates in the Biotechnology field. IvexSol generates 8.62% of Vigene's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is FUJIFILM Diosynth Biotechnologies a competitor of Vigene?

Acquisitions

No recent acquisitions found related to Vigene

Vigene Funding History

$7.5M$11.5M

Since Vigene was founded in 2012, it has participated in 3 rounds of funding. In total Vigene has raised $11.5M. Vigene's last funding round was on Apr 2020 for a total of $1.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$1M - $2M

U.S. Small Business Administration.

Equity
Mar 2020
$3M
-
Growth
Apr 2019
$7.5M

Since Vigene was founded in 2012, it has participated in 3 rounds of funding. In total Vigene has raised $11.5M. Vigene's last funding round was on Apr 2020 for a total of $1.0M

Investments

No recent investments found related to Vigene

Vigene News

March 31, 2020The Business Journals: Washington, D.C.

Rockville biotech jumps into COVID-19 fight as it rakes in new funding

The firm is now actively working with different entities to advance their COVID-19 vaccines.... See more »
March 23, 2020SEC.GOV

Vigene Biosciences received $3M in Equity Funding

Vigene Biosciences received $3M in Equity Funding... See more »
February 24, 2020FirstWord Pharma

Vigene Biosciences Awarded Patent for improvements in the packaging efficiency of recombinantly-modified adeno-associated virus (AAV)

ROCKVILLE, Md., Feb. 24, 2020 /PRNewswire/ -- Vigene Biosciences, Inc. (Vigene), a leading biotechnol... See more »
January 30, 2020The Business Journals: Baltimore

Rockville biotech opens new HQ as it goes on hiring spree

Vigene Biosciences Inc.'s has opened its new research facility in Rockville. The opening of a new lab... See more »
January 15, 2020Contract Pharma

ASC Therapeutics and Vigene Announced Long-Term Partnership

Partnership for gene therapy development and manufacturing.... See more »
May 24, 2019The Business Journals: Washington, D.C.

Rockville biotech raising $7.5M for new manufacturing facility

This is the first raise for the business, which has been profitable and fueled growth organically up ... See more »
April 29, 2019FinSMEs

Vigene Biosciences Receives Growth Capital Financing

Vigene Biosciences, a Rockville, MD-based...... See more »

Vigene Press Releases

August 15, 2018PR Newswire

Vigene Biosciences Ranks 81st on the 2018 Inc. 5000

NEW YORK, Aug. 15, 2018 /PRNewswire/ -- Inc. magazine today revealed that Vigene Biosciences is No. 8... See more »
April 16, 2018PR Newswire

Vigene Biosciences Announces Partnership With Virovek to Make High-Yield cGMP AAV Production Technology Accessible and Affordable

ROCKVILLE, Md., April 16, 2018 /PRNewswire/ -- Vigene Biosciences Inc. (Vigene), a leading biotechnol... See more »
November 8, 2017PR Newswire

Vigene Biosciences Partners with The Michael J. Fox Foundation to Distribute Alpha-synuclein Knockdown Viral Vectors for Parkinson's Disease Research

ROCKVILLE, Md., Nov. 8, 2017 /PRNewswire/ -- Vigene Biosciences, Inc. (Vigene), a leading biotechnolo... See more »
November 28, 2016Blackbird

Vigene Biosciences Acquires the cGMP Manufacturing Facility and Assets of Omnia Biosciences

ROCKVILLE, Md., Nov. 29, 2016 /PRNewswire/ - Vigene Biosciences, Inc. (Vigene), a leading biotechnolo... See more »

Vigene Videos

Social Media

Headquarters

5 Research Court

Rockville, Maryland20850

1-301-251-6638

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Vigene is a provider of molecular cloning and viral vector-based gene delivery services for research and clinical applications Vigene was founded in 2012. Vigene's headquarters is located in Rockville, Maryland, USA 20850. It has raised 11.5M in 3 rou...

CEO

Vigene's Chairman & CEO, Zairen Sun, currently has an approval rating of 86%. Vigene's primary competitors are Brammer Bio, Sirion-Biotech & IvexSol.

Website

vigenebio.com

Frequently Asked Questions about Vigene

  1. When was Vigene founded?

    Vigene was founded in 2012
  2. Who is Vigene's CEO?

    Vigene's CEO is Zairen Sun
  3. How much revenue does Vigene generate?

    Vigene generates $11.6M in revenue
  4. How much funding does Vigene have?

    Vigene has historically raised $11.5M in funding
  1. Where is Vigene's headquarters?

    Vigene's headquarters is in Rockville Maryland, USA
  2. How many employees does Vigene have?

    Vigene has 95 employees
  3. What sector does Vigene operate in?

    Vigene is in Biotechnology
  4. Who are Vigene's competitors?

    Vigene's top competitors are Brammer Bio, Sirion-Biotech, IvexSol